CLINICAL TRIALS PROFILE FOR ACETIC ACID
✉ Email this page to a colleague
All Clinical Trials for Acetic Acid
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00003697 ↗ | Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors | Completed | University of Glasgow | Phase 1 | 1995-10-01 | RATIONALE: Dimethylxanthenone acetic acid may stop the growth of cancer cells by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of dimethylxanthenone acetic acid in treating patients with solid tumors that have not responded to previous therapy. |
NCT00044213 ↗ | Trial to Assess Chelation Therapy (TACT) | Completed | National Center for Complementary and Integrative Health (NCCIH) | Phase 3 | 2003-09-01 | The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease. |
NCT00044213 ↗ | Trial to Assess Chelation Therapy (TACT) | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 2003-09-01 | The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease. |
NCT00044213 ↗ | Trial to Assess Chelation Therapy (TACT) | Completed | Mt. Sinai Medical Center, Miami | Phase 3 | 2003-09-01 | The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Acetic Acid
Condition Name
Clinical Trial Locations for Acetic Acid
Trials by Country
Clinical Trial Progress for Acetic Acid
Clinical Trial Phase
Clinical Trial Sponsors for Acetic Acid
Sponsor Name